Protagonist Therapeutics Inc(PTGX)— 技術面狀態
數據截至2026-11-02 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes.
移動平均線狀態
- 相對20日均線-0.1%
- 相對50日均線-2.3%
- 相對200日均線+19.2%
- 52週區間低於52週高點13.3% · 高於52週低點84.7%
- 連續走勢連續1個交易日下跌
- 50日均線交叉股價向下穿越50日均線(今日)
- 隨機指標%K 64.7 · %D 74.2(死亡交叉)
FAQ · from the current data · as of 2026-11-02
Quick answers
PTGX目前的Closelook訊號是什麼?
Pullback inside an uptrend stack — Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes.(截至2026-11-02;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
PTGX目前是否位於50日與200日均線上方?
截至2026-11-02,Protagonist Therapeutics Inc位於50日均線下方(-2.3%),200日均線上方(+19.2%);距20日均線-0.1%。
PTGX距52週高點有多遠?
截至2026-11-02,低於52週高點13.3%,高於52週低點84.7%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry